info@allievapharma.com

  • 24/7
    Customer Service
  • ISO 9001
    Certification Company
  • WHO-GMP
    Certified Company

All Products

OUR PRODUCTS

Allieva Pharma offers a wide range of pharmaceutical products including tablets, capsules, and injections. Our products are manufactured with high-quality standards and trusted across India and international markets.

SUNITCAP 50MG Sunitinib Malate Capsules 50mg by Allieva Pharma Private Limited

SUNITCAP 50MG

Sunitinib Malate Capsules 50mg

SUNITCAP 50 mg contains Sunitinib malate, an oral targeted anticancer medicine. It is a multi-targeted tyrosine kinase inhibitor (TKI) that blocks receptors involved in tumor growth, angiogenesis (blood vessel formation), and cancer cell survival, thereby slowing cancer progression.

View Details
SUNITCAP 25MG Sunitinib Malate Capsules 25mg by Allieva Pharma Private Limited

SUNITCAP 25MG

Sunitinib Malate Capsules 25mg

SUNITCAP 25 mg contains Sunitinib malate, an oral targeted anticancer medicine. It is a multi-targeted tyrosine kinase inhibitor (TKI) that inhibits receptors involved in tumor growth, angiogenesis, and cancer cell survival, thereby slowing disease progression.

View Details
SUNITCAP 12.5MG Sunitinib Malate Capsules 12.5mg by Allieva Pharma Private Limited

SUNITCAP 12.5MG

Sunitinib Malate Capsules 12.5mg

SUNITCAP 12.5 mg contains Sunitinib malate, an oral targeted anticancer medicine. It is a multi-targeted tyrosine kinase inhibitor (TKI) that blocks receptors involved in tumor growth, angiogenesis (blood vessel formation), and cancer cell survival, thereby slowing disease progression.

View Details
ALIMLIEVA 500MG Pemetrexed Injection IP 500mg by Allieva Pharma Private Limited

ALIMLIEVA 500MG

Pemetrexed Injection IP 500mg

ALIMLIEVA 500 mg contains Pemetrexed, a chemotherapy (anticancer) drug classified as a multitargeted antifolate antimetabolite. It inhibits key enzymes involved in purine and pyrimidine synthesis, leading to inhibition of DNA and RNA synthesis and cancer cell death. It is mainly used in non-squamous lung cancers.

View Details
ALIMLIEVA 100MG Pemetrexed Injection IP 100mg by Allieva Pharma Private Limited

ALIMLIEVA 100MG

Pemetrexed Injection IP 100mg

ALIMLIEVA 100 mg contains Pemetrexed, a chemotherapy (anticancer) medicine classified as a multitargeted antifolate. It inhibits several enzymes involved in DNA and RNA synthesis, leading to suppression of cancer cell growth. It is mainly used in non-squamous lung cancers.

View Details
OXALIEVA 100MG Oxaliplatin Injection USP 100mg by Allieva Pharma Private Limited

OXALIEVA 100MG

Oxaliplatin Injection USP 100mg

OXALIEVA 100 mg contains Oxaliplatin, a third-generation platinum-based chemotherapy (anticancer) drug. It forms DNA cross-links, inhibiting DNA synthesis and transcription, which leads to cancer cell death. Oxaliplatin is particularly effective in colorectal cancer and has lower nephrotoxicity and ototoxicity compared to cisplatin.

View Details
OXALIEVA 50MG Oxaliplatin Injection USP 50mg by Allieva Pharma Private Limited

OXALIEVA 50MG

Oxaliplatin Injection USP 50mg

OXALIEVA 50 mg contains Oxaliplatin, a third-generation platinum-based chemotherapy (anticancer) drug. It works by forming DNA cross-links, which inhibit DNA synthesis and transcription, leading to cancer cell death. Oxaliplatin is especially effective in colorectal cancer and has less kidney and hearing toxicity than cisplatin.

View Details
CISLIEVA 50MG Cisplatin Injection IP 50mg by Allieva Pharma Private Limited

CISLIEVA 50MG

Cisplatin Injection IP 50mg

CISLIEVA 50 mg contains Cisplatin, a platinum-based chemotherapy (anticancer) medicine. It works by forming DNA cross-links, which inhibit DNA replication and transcription, leading to death of rapidly dividing cancer cells. Cisplatin is widely used in many solid tumors.

View Details
CISLIEVA 10MG Cisplatin Injection IP 10 MG by Allieva Pharma Private Limited

CISLIEVA 10MG

Cisplatin Injection IP 10 MG

CISLIEVA 10 mg contains Cisplatin, a platinum-based chemotherapy (anticancer) drug. It works by forming DNA cross-links, which inhibit DNA synthesis and repair, leading to death of rapidly dividing cancer cells. Cisplatin is a cornerstone drug in many solid tumor chemotherapy regimens.

View Details
CARBOLIEVA 450MG Carboplatin Injection IP 450mg by Allieva Pharma Private Limited

CARBOLIEVA 450MG

Carboplatin Injection IP 450mg

CARBOLIEVA 450 mg contains Carboplatin, a platinum-based chemotherapy (anticancer) medicine. It acts by forming DNA cross-links, which inhibit DNA synthesis and repair, leading to death of rapidly dividing cancer cells. Compared to cisplatin, carboplatin generally causes less kidney and nerve toxicity.

View Details
CARBOLIEVA 150MG Carboplatin Injection IP 150mg by Allieva Pharma Private Limited

CARBOLIEVA 150MG

Carboplatin Injection IP 150mg

CARBOLIEVA 150 mg contains Carboplatin, a platinum-based chemotherapy (anticancer) drug. It works by forming DNA cross-links, which inhibit DNA synthesis and repair, leading to cancer cell death. Compared to cisplatin, carboplatin has less nephrotoxicity and neurotoxicity.

View Details
NAB-PACLIEVA 100MG Paclitaxel (Protien Bound Particles) for Injection Suspension 100 MG by Allieva Pharma Private Limited

NAB-PACLIEVA 100MG

Paclitaxel (Protien Bound Particles) for Injection Suspension 100 MG

NAB-PACLIEVA 100 mg contains Paclitaxel (protein-bound particles), also known as nab-paclitaxel. It is a chemotherapy (anticancer) drug in which paclitaxel is bound to human albumin nanoparticles. This formulation improves drug delivery to tumor cells and eliminates the need for solvent (Cremophor EL), reducing hypersensitivity reactions.

View Details

24/7 Clients Support

Best Price

Quality Assurance